Atlas Trials

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation

Clinical trial NCT01955616 · TERMINATED

Trial details

NCT number
NCT01955616
Sponsor
Motus Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2013-09-01
Primary completion
2015-05-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.